drugset / Trial / NCT01778101

Lansoprazole in Preterm Infants With Reflux

NCT01778101

Phase 2 Completed 5 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study is pilot study to evaluate safety and efficacy of lansoprazole in preterm infants with gastroesophageal reflux documented by 24hr pH impedance monitoring

Timeline

Start
2013-01
Primary completion
2013-05
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Lansoprazole Other / unclassified 1 mg/kg